NCT01285453View on ClinicalTrials.gov

Safety and Tolerability of ASA404 Administered in Combination With Docetaxel in Japanese Patients With Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

December 31, 2009

Conditions
Advanced or Recurrent Solid Tumors
Interventions
DRUG

vadimezan

Trial Locations (2)

Unknown

Novartis Investigative Site, Aichi

Novartis Investigative Site, Osaka

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY